Description
This research-grade peptide blend combines two well-characterized growth hormone secretagogues: CJC-1295 (No DAC) and Ipamorelin. Together, they form a dual-pathway approach to stimulating endogenous GH release via both GHRH and GHS mechanisms.
CJC-1295 (No DAC) is a shorter-acting GHRH analog designed to mimic natural pulsatile GH release, while Ipamorelin selectively targets the ghrelin receptor to enhance that pulse without impacting cortisol or prolactin levels.
This combo is frequently studied in models related to tissue recovery, muscle maintenance, body composition, and healthy aging — offering a powerful research platform for investigators studying endocrine and regenerative signaling.
⚠️ For research use only. Not intended for human or animal use. All claims reference published scientific literature.





